Informazioni cronologiche,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. ,Task 1: Abstract the triple verbalisation.,Task 2.1: Formulate a question when the answer is the subject of the abstraction of the verbalisation. ,Task 2.2: Formulate a question when the answer is the property of the abstraction of the verbalisation. ,Task 2.3: Formulate a question when the answer is the object of the abstraction of the verbalisation. 
,Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Issue 7.,Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Issue 7.,Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Issue 7.,Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Issue 7.,α-D-xylopyranose is a stereoisomer of β-L-arabinopyranose.,α-D-xylopyranose is a stereoisomer of β-L-arabinopyranose.,α-D-xylopyranose is a stereoisomer of β-L-arabinopyranose.,α-D-xylopyranose is a stereoisomer of β-L-arabinopyranose.,"A chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. The volume is 81.","A chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. The volume is 81.","A chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. The volume is 81.","A chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. The volume is 81","A chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates 
the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. The volume is 81.
","A chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates 
the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. The volume is 81.
","A chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates 
the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. The volume is 81.
","A chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates 
the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. The volume is 81.
","The effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic 
activity in rats were published on 01/08/1989.
","The effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic 
activity in rats were published on 01/08/1989.
","The effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic 
activity in rats were published on 01/08/1989.
","The effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic 
activity in rats were published on 01/08/1989.
",Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro.,Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro.,Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro.,Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro.,"Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. Published in 
Psychopharmacology.
","Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. Published in 
Psychopharmacology.
","Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. Published in 
Psychopharmacology.
","Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. Published in 
Psychopharmacology.
","Hsa-mir-3651 is encoded by MIR3651.
","Hsa-mir-3651 is encoded by MIR3651.
","Hsa-mir-3651 is encoded by MIR3651.
","Hsa-mir-3651 is encoded by MIR3651.
","Kynamro is an active ingredient in mipomersen.
",Kynamro is an active ingredient in mipomersen.,Kynamro is an active ingredient in mipomersen.,"Kynamro is an active ingredient in mipomersen.
","  Dofetilide is a significant drug interaction between thioridazine and dofetilide.
","  Dofetilide is a significant drug interaction between thioridazine and dofetilide.
","  Dofetilide is a significant drug interaction between thioridazine and dofetilide.
","  Dofetilide is a significant drug interaction between thioridazine and dofetilide.
",Cromoglicic acid is a World Health Organisation International Nonproprietary Name.,Cromoglicic acid is a World Health Organisation International Nonproprietary Name.,Cromoglicic acid is a World Health Organisation International Nonproprietary Name.,Cromoglicic acid is a World Health Organisation International Nonproprietary Name.,Hakone Onsen is located in the administrative territorial entity of Hakone.,Hakone Onsen is located in the administrative territorial entity of Hakone.,Hakone Onsen is located in the administrative territorial entity of Hakone.,Hakone Onsen is located in the administrative territorial entity of Hakone.,A-68930 interacts physically with the Dopamine receptor D5.,A-68930 interacts physically with the Dopamine receptor D5.,A-68930 interacts physically with the Dopamine receptor D5.,A-68930 interacts physically with the Dopamine receptor D5., The medical condition of breast cancer is treated with aminoglutethimide., The medical condition of breast cancer is treated with aminoglutethimide., The medical condition of breast cancer is treated with aminoglutethimide., The medical condition of breast cancer is treated with aminoglutethimide.,"Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. The author name is 
Alex Caminer.
","Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. The author name is 
Alex Caminer.
","Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. The author name is 
Alex Caminer.
","Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. The author name is 
Alex Caminer.
",Acepromazine has a role in antipsychotics.,Acepromazine has a role in antipsychotics.,Acepromazine has a role in antipsychotics.,Acepromazine has a role in antipsychotics.,"Chrysolaminarin has a melting point of 273 degree Celsius.
","Chrysolaminarin has a melting point of 273 degree Celsius.
","Chrysolaminarin has a melting point of 273 degree Celsius.
","Chrysolaminarin has a melting point of 273 degree Celsius.
","
The human chromosome 14 is the MIR134 chromosome.",The human chromosome 14 is the MIR134 chromosome.,The human chromosome 14 is the MIR134 chromosome.,The human chromosome 14 is the MIR134 chromosome.,"MIR541 has a forward strand orientation.
","MIR541 has a forward strand orientation.
","MIR541 has a forward strand orientation.
","MIR541 has a forward strand orientation.
",Hsa-mir-7973-2 has a genomic start of 51314032.,Hsa-mir-7973-2 has a genomic start of 51314032.,Hsa-mir-7973-2 has a genomic start of 51314032.,Hsa-mir-7973-2 has a genomic start of 51314032.,EGFR-AS1 has a genomic end of 55256627.,EGFR-AS1 has a genomic end of 55256627.,EGFR-AS1 has a genomic end of 55256627.,EGFR-AS1 has a genomic end of 55256627.,LINC01216 is expressed in putamen.,"LINC01216 is expressed in putamen.
","LINC01216 is expressed in putamen.
","LINC01216 is expressed in putamen.
","Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine 
(MDMA): interindividual differences due to polymorphisms and drug-drug interactions. 
It cites work on Patterns of ecstasy-associated hyponatremia in California.
","Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine 
(MDMA): interindividual differences due to polymorphisms and drug-drug interactions. 
It cites work on Patterns of ecstasy-associated hyponatremia in California.
","Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine 
(MDMA): interindividual differences due to polymorphisms and drug-drug interactions. 
It cites work on Patterns of ecstasy-associated hyponatremia in California.
","Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine 
(MDMA): interindividual differences due to polymorphisms and drug-drug interactions. 
It cites work on Patterns of ecstasy-associated hyponatremia in California.
","SCD163:MYH9 [cytosol] is part of sCD163 and it binds MYH9 in T-cells.
",SCD163:MYH9 [cytosol] is part of sCD163 and it binds MYH9 in T-cells.,"SCD163:MYH9 [cytosol] is part of sCD163 and it binds MYH9 in T-cells.

","SCD163:MYH9 [cytosol] is part of sCD163 and it binds MYH9 in T-cells.
","The cytogenetic location of MIR1913 is 6q27.
","The cytogenetic location of MIR1913 is 6q27.
","The cytogenetic location of MIR1913 is 6q27.
","The cytogenetic location of MIR1913 is 6q27.
","Benzamide, N-[9-(2-O-methyl-β-D-arabinofuranosyl)-9H-purin-6-yl]- is in the catalog of 
CAS COVID-19 Anti-Viral Candidate Compounds.
","Benzamide, N-[9-(2-O-methyl-β-D-arabinofuranosyl)-9H-purin-6-yl]- is in the catalog of 
CAS COVID-19 Anti-Viral Candidate Compounds.
","Benzamide, N-[9-(2-O-methyl-β-D-arabinofuranosyl)-9H-purin-6-yl]- is in the catalog of 
CAS COVID-19 Anti-Viral Candidate Compounds.
","Benzamide, N-[9-(2-O-methyl-β-D-arabinofuranosyl)-9H-purin-6-yl]- is in the catalog of 
CAS COVID-19 Anti-Viral Candidate Compounds.
","HOXB1:PBX1:PKNOX1 and MEIS1 at active HOXB1 chromatin [nucleoplasm] 
has part of HOXB1:PBX1:PKNOX1 [nucleoplasm].
","HOXB1:PBX1:PKNOX1 and MEIS1 at active HOXB1 chromatin [nucleoplasm] 
has part of HOXB1:PBX1:PKNOX1 [nucleoplasm].
","HOXB1:PBX1:PKNOX1 and MEIS1 at active HOXB1 chromatin [nucleoplasm] 
has part of HOXB1:PBX1:PKNOX1 [nucleoplasm].
","HOXB1:PBX1:PKNOX1 and MEIS1 at active HOXB1 chromatin [nucleoplasm] 
has part of HOXB1:PBX1:PKNOX1 [nucleoplasm].
",The isotretinoin anisatil has a mass of 448.261 dalton.,The isotretinoin anisatil has a mass of 448.261 dalton.,The isotretinoin anisatil has a mass of 448.261 dalton.,The isotretinoin anisatil has a mass of 448.261 dalton.,"Hsa-miR-1307-3p regulates (molecular biology) IL6R.
","Hsa-miR-1307-3p regulates (molecular biology) IL6R.
","Hsa-miR-1307-3p regulates (molecular biology) IL6R.
",Hsa-miR-1307-3p regulates (molecular biology) IL6R.,"2R,3R,5S,6R)-3-amino-6-methyloxane-2,5-diol are isomeric SMILES. C[C@@H]1[C@H]([C@@H]
(O1)O)N)O.
","2R,3R,5S,6R)-3-amino-6-methyloxane-2,5-diol are isomeric SMILES. C[C@@H]1[C@H]([C@@H]
(O1)O)N)O.
","2R,3R,5S,6R)-3-amino-6-methyloxane-2,5-diol are isomeric SMILES. C[C@@H]1[C@H]([C@@H]
(O1)O)N)O.
","2R,3R,5S,6R)-3-amino-6-methyloxane-2,5-diol are isomeric SMILES. C[C@@H]1[C@H]([C@@H]
(O1)O)N)O.
",B430212C06Rik is found in the taxon house mouse.,B430212C06Rik is found in the taxon house mouse.,B430212C06Rik is found in the taxon house mouse.,B430212C06Rik is found in the taxon house mouse.,"Methane, dichlorodinitro- is canonical SMILES. C([N+](=O)[O-])(Cl)Cl.","Methane, dichlorodinitro- is canonical SMILES. C([N+](=O)[O-])(Cl)Cl.","Methane, dichlorodinitro- is canonical SMILES. C([N+](=O)[O-])(Cl)Cl.","Methane, dichlorodinitro- is canonical SMILES. C([N+](=O)[O-])(Cl)Cl.","4-hydroxy-6-(prop-1-en-1-yl)pyran-2-one has the chemical formula of C8H8O3.
","4-hydroxy-6-(prop-1-en-1-yl)pyran-2-one has the chemical formula of C8H8O3.
","4-hydroxy-6-(prop-1-en-1-yl)pyran-2-one has the chemical formula of C8H8O3.
","4-hydroxy-6-(prop-1-en-1-yl)pyran-2-one has the chemical formula of C8H8O3.
"
10/13/2022 21:54:55,An article has an issue x.,What article has an issue x?,What is the relation between an article and x?,What issue does an article have?,A chemical compound is a stereoisomer of a chemical compound.,What chemical compound is a stereoisomer of a chemical compound?,What is the relation between two chemical compounds?,What chemical compound is a stereoisomer of a chemical compound?,The volume of an article is x.,What article has a volume x?,What is the relation between an article and x?,What volume does an article have?,An article has pages x.,What article has pages x?,What is the relation between an article and x?,What are the pages of an article?,An article was published on a time.,What article was published on a time?,What is the relation between an article and a time?,What time was an article published on?,-,-,-,-,An article is published in a journal.,What article is published in a journal?,What is the relation between an article and a journal?,What journal is an article published in?,a microRNA is encoded by a RNA.,What microRNA is encoded by a RNA?,What is the relation between a microRNA and a RNA?,What RNA encodes a microRNA?,A drug is an active ingredient in a product.,What drug is an active ingredient in a product?,What is the relation between a drug and a product?,What product is a drug an active ingredient in?,A chemical compound is a significant drug interaction between a chemical compound and a chemical compound.,What chemical compound is a significant interaction between two chemical compounds?,What is the relation between two chemical compounds?,What chemical compound is a chemical compound a significant drug interaction of?,-,-,-,-,An onsen is located in a town.,What onsen is located in a town?,What is the relation between an onsen and a town? ,What town is an onsen located in?,A chemical compound interacts physically with a protein.,What chemical compound interacts physically with a protein?,What is the relation between a chemical compound and a protein?,What protein does a chemical compound physically interacts with?,The medical condition of a cancer is treated with a chemical compound.,What chemical compound treats the medical condition of cancer?,What is the relation between the medical condition of cancer and a chemical compound?,What medical condition is treated with a chemical compound?,The author name of an article is x.,What article has an author name x?,What is the relation between an article and an author?,What author is the author of an article?,A chemical compound has a role in a medication.,What chemical compound has a role in a medication?,What is the relation between a chemical compound and a medication?,What medication does a chemical compound have a role in?,A chemical compound has a melting point of x.,What chemical compound has a melting point of x?,What is the relation between a chemical compound and a melting point?,What melting point does a chemical compound have?,A human chromosome is a RNA chromosome.,What human chromosome is a RNA chromosome?,What is the relation between a human chromosome and a RNA chromosome?,What RNA chromosome is a human chromosome?,A RNA has an orientation.,What RNA has an orientation?,What is the relation between a RNA and an orientation?,What orientation does a RNA have?,A microRNA has a genomic start x.,What microRNA has a genomic start x?,What is the relation between a microRNA and a genomic start?,What genomic start does a microRNA have?,A RNA has a genomic end of x.,What RNA has a genomic end x?,What is the relation between a RNA and a genomic end?,What genomic end does a RNA have?,A RNA is expressed in a structure.,What RNA is expressed in a structure?,What is the relation between a RNA and a structure?,What structure is a RNA expressed in?,An article cites work on an article.,What article cites work on an article?,What is the relation between two articles?,What articles does an article cite on?,A micromolecular complex is part of a reaction.,What micromolecular complex is part of a reaction?,What is the relation between a micromolecular complex and a reaction?,What reaction is a micromolecular complex a part of?,The cytogenetic location of a RNA is x.,What RNA has a cytogenic location of x?,What is the relation between a RNA and a cytogenic location?,What cytogenic location does a RNA have?,A chemical compound is in a catalog x.,What chemical compound is in a catalog x?,What is the relation between a chemical compound and a catalog?,What catalog is a chemical compound in?,A macromolecular complex has part a macromolecular complex.,What macromolecular complex has part a macromolecular complex?,What is the relation between two macromolecular complexes?,What macromolecular complex is a macromolecular complex a part of?,A chemical compound has a mass of x.,What chemical compound has a mass x?,What is the relation between a chemical compound and a mass?,What mass does a chemical compound have?,A microRNA regulates a gene.,What microRNA regulates a gene?,What is the relation between a microRNA and a gene?,What gene does a microRNA regulate?,-,-,-,-,A RNA is found in a taxon mammal.,What RNA is found in a taxon mammal?,What is the relation between a RNA and a taxon mammal?,What taxon is a RNA found in?,-,-,-,-,A chemical compound has a chemical formula of x.,What chemical compound has a chemical formula of x?,What is the relation between a chemical compound and a chemical formula?,What chemical formula does a chemical compound have?
10/13/2022 21:54:55,An article has an issue x.,What article has an issue x?,What is the relation between an article and x?,What issue does an article have?,A chemical compound is a stereoisomer of a chemical compound.,What chemical compound is a stereoisomer of a chemical compound?,What is the relation between two chemical compounds?,What chemical compound is a stereoisomer of a chemical compound?,The volume of an article is x.,What article has a volume x?,What is the relation between an article and x?,What volume does an article have?,An article has pages x.,What article has pages x?,What is the relation between an article and x?,What are the pages of an article?,An article was published on a time.,What article was published on a time?,What is the relation between an article and a time?,What time was an article published on?,-,-,-,-,An article is published in a journal.,What article is published in a journal?,What is the relation between an article and a journal?,What journal is an article published in?,a microRNA is encoded by a RNA.,What microRNA is encoded by a RNA?,What is the relation between a microRNA and a RNA?,What RNA encodes a microRNA?,A drug is an active ingredient in a product.,What drug is an active ingredient in a product?,What is the relation between a drug and a product?,What product is a drug an active ingredient in?,A chemical compound is a significant drug interaction between a chemical compound and a chemical compound.,What chemical compound is a significant interaction between two chemical compounds?,What is the relation between two chemical compounds?,What chemical compound is a chemical compound a significant drug interaction of?,-,-,-,-,An onsen is located in a town.,What onsen is located in a town?,What is the relation between an onsen and a town? ,What town is an onsen located in?,A chemical compound interacts physically with a protein.,What chemical compound interacts physically with a protein?,What is the relation between a chemical compound and a protein?,What protein does a chemical compound physically interacts with?,The medical condition of a cancer is treated with a chemical compound.,What chemical compound treats the medical condition of cancer?,What is the relation between the medical condition of cancer and a chemical compound?,What medical condition is treated with a chemical compound?,The author name of an article is x.,What article has an author name x?,What is the relation between an article and an author?,What author is the author of an article?,A chemical compound has a role in a medication.,What chemical compound has a role in a medication?,What is the relation between a chemical compound and a medication?,What medication does a chemical compound have a role in?,A chemical compound has a melting point of x.,What chemical compound has a melting point of x?,What is the relation between a chemical compound and a melting point?,What melting point does a chemical compound have?,A human chromosome is a RNA chromosome.,What human chromosome is a RNA chromosome?,What is the relation between a human chromosome and a RNA chromosome?,What RNA chromosome is a human chromosome?,A RNA has an orientation.,What RNA has an orientation?,What is the relation between a RNA and an orientation?,What orientation does a RNA have?,A microRNA has a genomic start x.,What microRNA has a genomic start x?,What is the relation between a microRNA and a genomic start?,What genomic start does a microRNA have?,A RNA has a genomic end of x.,What RNA has a genomic end x?,What is the relation between a RNA and a genomic end?,What genomic end does a RNA have?,A RNA is expressed in a structure.,What RNA is expressed in a structure?,What is the relation between a RNA and a structure?,What structure is a RNA expressed in?,An article cites work on an article.,What article cites work on an article?,What is the relation between two articles?,What articles does an article cite on?,A micromolecular complex is part of a reaction.,What micromolecular complex is part of a reaction?,What is the relation between a micromolecular complex and a reaction?,What reaction is a micromolecular complex a part of?,The cytogenetic location of a RNA is x.,What RNA has a cytogenic location of x?,What is the relation between a RNA and a cytogenic location?,What cytogenic location does a RNA have?,A chemical compound is in a catalog x.,What chemical compound is in a catalog x?,What is the relation between a chemical compound and a catalog?,What catalog is a chemical compound in?,A macromolecular complex has part a macromolecular complex.,What macromolecular complex has part a macromolecular complex?,What is the relation between two macromolecular complexes?,What macromolecular complex is a macromolecular complex a part of?,A chemical compound has a mass of x.,What chemical compound has a mass x?,What is the relation between a chemical compound and a mass?,What mass does a chemical compound have?,A microRNA regulates a gene.,What microRNA regulates a gene?,What is the relation between a microRNA and a gene?,What gene does a microRNA regulate?,-,-,-,-,A RNA is found in a taxon mammal.,What RNA is found in a taxon mammal?,What is the relation between a RNA and a taxon mammal?,What taxon is a RNA found in?,-,-,-,-,A chemical compound has a chemical formula of x.,What chemical compound has a chemical formula of x?,What is the relation between a chemical compound and a chemical formula?,What chemical formula does a chemical compound have?